Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5)

Description

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags, pre-filled syringes & elastomeric devices. This procurement is being managed by the PPSA on behalf of the Royal Devon University Healthcare NHS Foundation Trust acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust. Lot 1: Supply of various products in bags, pre-filled syringes to include Arsenic Trioxide, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Blinatumomab, Brentuximab, Bupivacaine, Carfilzomib, Cetuximab, Daratumumab, Eribulin Mesylate, Etoposide, Fludarabine Fluorouracil elastomeric devices, Ifosfamide, Infliximab, Ipilimumab, Methotrexate, Natalizumab, Obinutuzumab, Paclitaxel Albumin, Panitumumab, Pemetrexed, Pertuzumab, Rituximab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Vinorelbine.